The study is believed to be the first time human colon organoids have been successfully tissue engineered in this manner. The technology allows diseases of the colon to be studied in unprecedented detail in a human modeling system.
Plasticell has secured Biomedical Catalyst funding from Innovate UK to create a safe, effective red blood cell substitute for human clinical transfusion.